Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®
Source: eagletribune.com
Nobelpharma Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nobelpharma Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nobelpharma Co Today - Breaking & Trending Today
Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
/PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device...
Source: prnewswire.com
Tokyo researchers work toward 'dream' COVID-19 vaccine that gives protection for life
News and analytical articles about Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan.
Source: akipress.com
Scientist reveals when Covid vaccine with lifelong protection might be available
A Covid-19 vaccine potentially able to give lifelong protection has proved effective on mice and primates and is set for clinical trials. Production is planned for 2024, Japanese scientist Michinori Kohara told the Japan Times.
Source: rt.com
Japan Is Working on a COVID-19 Vaccine That Offers Lifelong Immunity
While pharma companies focus on developing variant-specific boosters, Japan is working on a vaccine that could offer lifelong immunity.
Source: interestingengineering.com